Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Tables)

v3.21.1
Segment Information (Tables)
 3 Months Ended
Mar. 31, 2021
Segment Reporting [Abstract]  
Schedule of reportable business segment information
Reportable business segment information is as follows (dollar amounts in thousands):
  Three Months Ended
March 31,
  2021 2020
Net sales:    
Asia $ 35,755  $ 30,958 
Europe 22,200  20,627 
North America 37,762  38,757 
Latin America and Other 6,704  5,584 
Total net sales 102,421  95,926 
Contribution margin (1):    
Asia 15,319  14,527 
Europe 6,796  6,831 
North America 15,440  14,419 
Latin America and Other 3,632  2,450 
Total contribution margin 41,187  38,227 
Selling, general and administrative expenses (2) 33,552  31,065 
Operating income 7,635  7,162 
Other loss, net (1,933) (2,410)
Income before provision for income taxes $ 5,702  $ 4,752 
_________________________________________

(1)   Contribution margin consists of net sales less cost of sales and volume incentives expense.
(2)  Service fees in China totaled $2.8 million and $1.9 million for the three-month periods ended March 31, 2021 and 2020, respectively. These service fees are included in selling, general and administrative expenses.
Schedule of consolidated net sales revenue by geographical locations From an individual country perspective, the United States and South Korea comprise 10 percent or more of consolidated net sales for the three-month periods ended March 31, 2021 and 2020, as follows (dollar amounts in thousands):
  Three Months Ended
March 31,
  2021 2020
Net sales:    
United States $ 34,920  $ 35,839 
South Korea 14,809  16,389 
Other 52,692  43,698 
  $ 102,421  $ 95,926 
Schedule of revenue generated by each of the Company's product lines Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):
  Three Months Ended
March 31,
  2021 2020
Asia    
General health $ 11,292  $ 9,046 
Immune 203  201 
Cardiovascular 9,903  9,339 
Digestive 6,871  6,156 
Personal care 2,524  3,005 
Weight management 4,962  3,211 
  35,755  30,958 
Europe    
General health $ 9,472  $ 7,961 
Immune 2,016  2,444 
Cardiovascular 2,992  2,897 
Digestive 5,540  4,931 
Personal care 1,426  1,751 
Weight management 754  643 
  22,200  20,627 
North America    
General health $ 16,270  $ 15,464 
Immune 4,874  7,798 
Cardiovascular 4,225  4,167 
Digestive 9,463  8,241 
Personal care 1,819  1,929 
Weight management 1,111  1,158 
  37,762  38,757 
Latin America and Other    
General health $ 1,976  $ 1,614 
Immune 811  809 
Cardiovascular 478  378 
Digestive 2,870  2,362 
Personal care 345  252 
Weight management 224  169 
  6,704  5,584 
  $ 102,421  $ 95,926 
Schedule of consolidated property, plant and equipment by geographical locations From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):
  March 31,
2021		 December 31,
2020
Property, plant and equipment:    
United States $ 48,693  $ 50,025 
Other 3,859  4,330 
Total property, plant and equipment, net $ 52,552  $ 54,355 
Schedule of assets per segment
Total assets per segment is set forth below (dollar amounts in thousands):
March 31,
2021		 December 31,
2020
Assets:    
Asia $ 84,668  $ 82,572 
Europe 16,533  16,398 
North America 135,710  142,324 
Latin America and Other 8,920  8,204 
Total assets $ 245,831  $ 249,498